Supplementary Figure S3 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression

作者：Blanca Rius‐Sansalvador, Anastasia Chrysovalantou Chatziioannou, Pekka Keski‐Rahkonen, Nivonirina Robinot, Ferrán Moratalla-Navarro, Núria Moragas, Elisabet Guinó, Mazda Jenab, Francisco D. Morón-Duran, Carmen Atencia, Gemma Ibáñez‐Sanz, L. Rodriguez Alonso, Alfredo Mata Bilbao, Ana García‐Rodríguez, Hwayoung Noh, E Fryer, R. Zamora-Ros, Olatz Mokoroa, Iosu Delfrade, Saverio Caini, José María Huerta, Thérèse Truong, Gianluca Severi, Yazdan Asgari, ­Rosario ­Tumino, Salvatore Panico, Anne Tjønneland, Agnetha Linn Rostgaard‐Hansen, María‐José Sánchez, Valeria Pala, Fulvio Ricceri, Marc J. Gunter, Vı́ctor Moreno, Mireia Obón‐Santacana · 年份：2026 · DOI：10.1158/1055-9965.33143615 · 研究领域：Medicine、Internal medicine、Oncology、Computational biology、Genetics、Bioinformatics、Biology

<p>Supplementary Figure S3. Forest plots of Previous Studies. Forest plot showing the odds ratios and 95% confidence intervals for metabolic features associated with Colorectal Cancer status. The results are compared with previous studies. Red squares represent the current study, while blue and green squares indicate findings from prior research. The “Compound” column lists the metabolite names or feature identifiers as reported in those previous studies, while “Mass@RT” corresponds to the matching metabolic features identified in our dataset. CRC: Colorectal Cancer, Precancerous Lesions (Low, Intermediate and High Risk Lesions).</p>